A cease trade order (CTO) was issued by the Ontario Securities Commission on Aug. 20, 2024, due to Medicine Man Technologies Inc.'s failure to file the following periodic disclosure:

• Interim financial statements for the period ended March 31, 2024;
• Management's discussion and analysis relating to the interim financial statements for the period ended March 31, 2024;
• Interim financial statements for the period ended June 30, 2024;
• Management's discussion and analysis relating to the interim financial statements for the period ended June 30, 2024;
• Certification of the foregoing filings as required by National Instrument 52-109, Certification of Disclosure in Issuers' Annual and Interim Filings.

The common shares of Medicine Man have been suspended pursuant to the CTO.